First report of KPC-producing Klebsiella pneumoniae in Croatia

Journal of Chemotherapy

Volumn 24, Issue 4, 2012, Pages 237-239

  Bedenić, Branka ^a,b   Mazzariol, Annarita ^c   Plečko, Vanda ^a,b   Bošnjak, Zrinka ^b   Barl, Petra ^a   Vraneš, Jasmina ^a   Cornaglia, Giuseppe ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Klebsiella pneumoniae; KPC beta lactamase; Meropenem

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; GENTAMICIN; KLEBSIELLA PNEUMONIAE CARBAPENEMASE 2 BETA LACTAMASE; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACUTE MYELOBLASTIC LEUKEMIA; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CANCER DIAGNOSIS; CANCER PATIENT; CASE REPORT; CLONE; CROATIA; GENE SEQUENCE; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; STAPHYLOCOCCUS AUREUS; SUBDURAL HEMATOMA;

AGED; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROATIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FATAL OUTCOME; HEMATOMA, SUBDURAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MENINGITIS, BACTERIAL; POSTOPERATIVE COMPLICATIONS;

EID: 84866237928     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000017     Document Type: Article

References (29)

1. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2007;2:501-12.
2. Urban C, Rahal JJ. Klebsiella and extended-spectrum blactamases. Int J Antimicrob Agents. 1997;8:37-43.
3. Yigit H, Quennan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing b-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151-61.
4. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing b-lactamase KPC in a Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother. 2007;52(2):796-7.
5. Navon-Venezia S, Chmeltnisky I, Leavitt A, Schwaber MJ, Carmely Y. Plasmid-mediated imipenem hydrolyzing enzyme KPC-2 among carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50:3098-101.
6. Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miringou V, Kontou S, et al. VIM-1 metallo-b-lactamase-producing Klebsiella pnuemoniae strains in Greek Hospital. J Clin Microbiol. 2003;41(8):3893-6.
7. Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-b-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerging Infect Dis. 2011;17:103-6.
8. Yan JJ, Ko WC, Tsai SH, Wu HM, Wu JJ. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a University Medical Center in Taiwan. J Clin Microbiol. 2001;39:4433-9.
9. Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48 persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy. 2008;54:101-6.
10. Gulmez D, Woodford N, Palepou MF, Mushtag S, Metan G, Yakopogulklan Y, et al. Carbapenem resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48 like carbapenemase and outer membrane protein loss. Int J Antimicrob Agents. 2008;31(6):523-6.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI/ NCCLS M100-S17. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
12. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum b-lactamases conferring transferable resistance to newer b-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10(4):867-78.
13. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA-double-disk synergy test for differentiating metallo-b-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003;41:4623-9.
14. Walsh TR, Bolmstrom A, Gales A. Evaluation of new E test for detecting metallo-b-lactamases in routine clinical testing J Clin Microbiol. 2002;40:2755-9.
15. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. A sensitive screening test for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47(6):1631-9.
16. Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V, editor. Antibiotics in laboratory medicine. 2nd ed. Baltimore (MD): Williams & Wilkins; 1986. p. 683-721.
17. Matthew MA, Harris AM, Marshall MJ, Ross GW. The use of isoelectric focusing for detection and identification of blactamases. J Gen Microbiol. 1975;88:169-78.
18. Nuesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV b-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996;15(5):398-402.
19. Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH. Molecular characterization by PCR restriction fragment polymorphism of TEM b-lactamases. FEMS Microbiol Lett. 1995;134(2-3):203-8.
20. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum b-lactamases in the UK. J Antimicrob Chemother. 2004;54(4):735-43.
21. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153-62.
22. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumonia nosocomial isolates. J Clin Microbiol. 2005;43:4178-82.
23. Diestra K, Miro E, Navarro D, Cuquet J, Coll P, Navarro F. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin Microbiol Infect. 2011;17(7):1032-6.
24. Orsi GB, Garcia-Fernandez A, Giordano A, Venditti C, Bencardino A, Gianfreda R, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumonae in hospitalized patients. J Hospit Infect. 2011;78(1):54-8.
25. Baboue B, Widmer AF, Dubuis O, Ciardo D, Droz S, Betsch BY, et al. Emergence of four cases of KPC-2 and KPC-3-arrying Klebsiella pneumoniae introduced to Switzerland 2009-10. Euro Surveillance. 2011;16(11): Epub.
26. Steinmann, J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, et al. Outbreak due to a Klebsiella pneumonia strain harbouring KPC-2 and VIM-1 in a German University hospital, July 2010 to January 2011. Euro Surveill. 2011;16(33): Epub.
27. Bogaerts P, Montasinos I, Rodriguez-Villalobos H, Blairon L, Deplano A. Glupczynski Y. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. J Antimicrob Chemother. 2010;65:361-376.
28. Richter S, Frasson I, Bergo C, Parisi S, Cavallaro A, Palu G. Transfer of KPC-2 carbapenemase from Klebsiella pneumonia to Escherichia coli in a patient: The first case in Europe. J Clin Microbil. 2011;49(5):2040-2042.
29. Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. First report of Klebsiella oxytoca strains coproducing KPC-2 and IMP-8 carbapenemases. Antimicrob Agents Chemother. 2011;55(6):2937-2941.